barriers to conducting clinical trials

R&D

Take the hybrid road to bring clinical trials to patients

As the landscape of clinical trials evolves, decentralised clinical trials (DCTs) have emerged to put patients at the centre of the research process.

R&D

Science 37 UCB pharma virtual clinical trials

Focus on the positive to stop public perception being a barr...

Public misconceptions surrounding the process, its risks and its benefits remain a significant barrier to clinical trial participation, which is not surprising in a world where the only int

News

Chiesi signs $1.9bn deal to buy KalVista and its HAE drug

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

barriers to conducting clinical trials

Editor's Picks